EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

ganoderic acid B

Supplier Sponsors

CAS Number: 81907-61-1Picture of molecule3D/inchi
FDA UNII: AV74TFJ3IS
Nikkaji Web:J39.405J
XlogP3-AA:2.20 (est)
Molecular Weight:516.67508000
Formula:C30 H44 O7
NMR Predictor:Predict (works with chrome, Edge or firefox)
Category:natural substances and extractives
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Soluble in:
 water, 1.905 mg/L @ 25 °C (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
None found
 
Suppliers:
Alfa Biotechnology
For experimental / research use only.
Ganoderic Acid B 98%
BOC Sciences
For experimental / research use only.
Ganoderic acid B >98%
Odor: characteristic
Use: Ganoderic acid B (GAB) possesses various pharmaceutical effects and has been used as a chemical marker in quality control of G. lucidum and related products
Carbosynth
For experimental / research use only.
Ganoderic Acid B
Santa Cruz Biotechnology
For experimental / research use only.
Ganoderic Acid B
 
Safety Information:
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
natural substances and extractives
Recommendation for ganoderic acid B usage levels up to:
 not for fragrance use.
 
Recommendation for ganoderic acid B flavor usage levels up to:
 not for flavor use.
 
Safety References:
EPI System: View
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :471003
National Institute of Allergy and Infectious Diseases:Data
(2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
Chemidplus:0081907611
 
References:
 (2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
NIST Chemistry WebBook:Search Inchi
Pubchem (cid):471003
Pubchem (cas):81907-61-1
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
HMDB (The Human Metabolome Database):HMDB35719
FooDB:FDB014443
VCF-Online:VCF Volatile Compounds in Food
ChemSpider:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 ganoderma lucidum
Search PMC Picture
 
Synonyms:
(2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid
 lanost-8-en-26-oic acid, 3,7-dihydroxy-3,11,23-trioxo-, (7beta,15alpha,25R)-
 

Articles:

PubMed:[Ganoderma triterpenoids from aqueous extract of Ganoderma lucidum].
PubMed:Triterpenoids fromGanoderma luciduminhibit the activation of EBV antigens as telomerase inhibitors.
PubMed:Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
PubMed:A Validated Reverse-Phase HPLC Method for Quantitative Determination of Ganoderic Acids A and B in Cultivated Strains of Ganoderma spp. (Agaricomycetes) Indigenous to India.
PubMed:Screening and Analysis of the Marker Components in Ganoderma lucidum by HPLC and HPLC-MSnwith the Aid of Chemometrics.
PubMed:Ganoderic acid B's influence towards the therapeutic window of trifluoperazine (TFP).
PubMed:Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells.
PubMed:Structural identification of the metabolites of ganoderic acid B from Ganoderma lucidum in rats based on liquid chromatography coupled with electrospray ionization hybrid ion trap and time-of-flight mass spectrometry.
PubMed:Pharmacokinetics of ganoderic acid D and its main metabolite by liquid chromatography-tandem mass spectrometry.
PubMed:[Determination of nine triterpenoid acids from Ganoderma lucidum of different producting areas by HPLC].
PubMed:Quality Difference Study of Six Varieties of Ganoderma lucidum with Different Origins.
PubMed:Interaction of ganoderic acid on HIV related target: molecular docking studies.
PubMed:Triterpenoids with neurotrophic activity from Ganoderma lucidum.
PubMed:Sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of five ganoderic acids in Ganoderma lucidum and its related species.
PubMed:[Extraction of triterpenoids from fruiting [corrected] bodies of Ganoderma lucidum by supercritical fluid extraction].
PubMed:[Advances of pharmacological effects of triterpenes from Ganoderma lucidum].
PubMed:[Effects of places and stages on the contents of ganoderic acid B from Ganoderma lucidum].
PubMed:Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum.
 
Notes:
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy